TBPH icon

Theravance Biopharma

121 hedge funds and large institutions have $431M invested in Theravance Biopharma in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

22% less capital invested

Capital invested by funds: $552M → $431M (-$121M)

26% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 47

Holders
121
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22K
Puts
$23K
Net Calls
Net Calls Change

Top Sellers

1 -$7.4M
2 -$7.21M
3 -$3.4M
4
Jane Street
Jane Street
New York
-$3.03M
5
NM
Newtyn Management
New York
-$2.3M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$160K
77
$147K
78
$139K
79
$136K
80
$134K
81
$132K
82
$118K
83
$116K
84
$110K
85
$107K
86
$106K
87
$104K
88
$102K
89
$97K
90
$92.1K
91
$90.6K
92
$89.7K
93
$86K
94
$54.6K
95
$52.3K
96
$26K
97
$24.9K
98
$19.5K
99
$17K
100
$15K